Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction

NCT01547598 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: travoprost ophthalmic solution 0.004%
DRUG: travoprost 0.004% / timolol 0.5% combination ophthalmic solution
DRUG: Bimatoprost ophthalmic solution 0.01%

Sponsor

Allergan